Email bulletins


April 2017

  • News from the 2017 International Liver Congress
  • WHO Global Hepatitis Report 2017
  • New hepatitis B clinical guidelines from EASL
  • HCV reimbursement criteria in Europe
  • Direct-acting antivirals and liver cancer risk
  • Hepatitis C treatment for children
  • AbbVie combination
  • HCV treatment reduces cardiovascular risk
  • Parkinson’s disease and hepatitis
  • Statins reduce the risk of decompensation
  • Antibiotic prophylaxis reduces mortality in decompensated cirrhosis
  • Coming soon: HR17
  • Is this your copy of the infohep news bulletin?

March 2017

  • Early treatment for hepatitis C
  • Access to hepatitis C treatment in South East Asia
  • Cancers
  • Liver cancer and treatment for viral hepatitis
  • Direct-acting antiviral treatment achieves high cure rates in the most advanced liver disease patients with HIV co-infection
  • Glecaprevir/pibrentasvir combination does not interact with HIV medications
  • Hepatitis A outbreak in Europe
  • Hepatitis C community summit, 18 & 19 April, Amsterdam
  • Is this your copy of the infohep news bulletin?